Advertisement
Research Article Free access | 10.1172/JCI119207
Clinica Pediatrica, Università degli Studi di Pavia, IRCCS Policlinico San Matteo, Italy.
Find articles by De Benedetti, F. in: JCI | PubMed | Google Scholar
Clinica Pediatrica, Università degli Studi di Pavia, IRCCS Policlinico San Matteo, Italy.
Find articles by Alonzi, T. in: JCI | PubMed | Google Scholar
Clinica Pediatrica, Università degli Studi di Pavia, IRCCS Policlinico San Matteo, Italy.
Find articles by Moretta, A. in: JCI | PubMed | Google Scholar
Clinica Pediatrica, Università degli Studi di Pavia, IRCCS Policlinico San Matteo, Italy.
Find articles by Lazzaro, D. in: JCI | PubMed | Google Scholar
Clinica Pediatrica, Università degli Studi di Pavia, IRCCS Policlinico San Matteo, Italy.
Find articles by Costa, P. in: JCI | PubMed | Google Scholar
Clinica Pediatrica, Università degli Studi di Pavia, IRCCS Policlinico San Matteo, Italy.
Find articles by Poli, V. in: JCI | PubMed | Google Scholar
Clinica Pediatrica, Università degli Studi di Pavia, IRCCS Policlinico San Matteo, Italy.
Find articles by Martini, A. in: JCI | PubMed | Google Scholar
Clinica Pediatrica, Università degli Studi di Pavia, IRCCS Policlinico San Matteo, Italy.
Find articles by Ciliberto, G. in: JCI | PubMed | Google Scholar
Clinica Pediatrica, Università degli Studi di Pavia, IRCCS Policlinico San Matteo, Italy.
Find articles by Fattori, E. in: JCI | PubMed | Google Scholar
Published February 15, 1997 - More info
Stunted growth is a major complication of chronic inflammation and recurrent infections in children. Systemic juvenile rheumatoid arthritis is a chronic inflammatory disorder characterized by markedly elevated circulating levels of IL-6 and stunted growth. In this study we found that NSE/hIL-6 transgenic mouse lines expressing high levels of circulating IL-6 since early after birth presented a reduced growth rate that led to mice 50-70% the size of nontransgenic littermates. Administration of a monoclonal antibody to the murine IL-6 receptor partially reverted the growth defect. In NSE/hIL-6 transgenic mice, circulating IGF-I levels were significantly lower than those of nontransgenic littermates; on the contrary, the distribution of growth hormone pituitary cells, as well as circulating growth hormone levels, were normal. Treatment of nontransgenic mice of the same strain with IL-6 resulted in a significant decrease in IGF-I levels. Moreover, in patients with systemic juvenile rheumatoid arthritis, circulating IL-6 levels were negatively correlated with IGF-I levels. Our findings suggest that IL-6-mediated decrease in IGF-I production represents a major mechanism by which chronic inflammation affects growth.